Search for the antigen-specificity of homogeneous IgG components (H-IgG) after allogeneic bone marrow transplantation

Bone Marrow Transplantation

Volumn 17, Issue 5, 1996, Pages 825-833

  Gerritsen, E J A ^a,g   Van Tol, M J D ^a   Ballieux, P ^a   Voesten, A ^a   Weiland, H T ^a   Van Venrooij, W J ^b   Daha, M R ^a   Geertzen, H G M ^c   Rijkers, G T ^d   Gmelig Meyling, F H J ^e   Claas, F J H ^a   Radl, J ^f   Vossen, J M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c CENTRAL LABORATORY   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f TNO   (Netherlands)

^g HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

Allogeneic BMT; Antigen specificity; Homogeneous IgG

Indexed keywords

ALLOANTIGEN; AUTOANTIGEN; IMMUNOGLOBULIN G; TETANUS TOXOID; VIRUS ANTIGEN;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIBODY PRODUCTION; ANTIGEN ANTIBODY REACTION; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; CHILD; CONTROLLED STUDY; HERPES VIRUS; HUMAN; IMMUNOGLOBULIN PRODUCTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; VACCINATION;

ADULT; ANTIBODY SPECIFICITY; ANTIGENS; B-LYMPHOCYTES; BONE MARROW TRANSPLANTATION; CASE-CONTROL STUDIES; CHILD; HUMANS; IMMUNOBLOTTING; IMMUNOGLOBULIN G; RETROSPECTIVE STUDIES; TETANUS TOXOID; TRANSPLANTATION, HOMOLOGOUS; VACCINATION;

EID: 15844412245     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Small TN, Keever CA, Weiner-Fedus S et al. B-cell differentiation following autologous. conventional or T-cell depleted bone marrow transplantation: a recapitulation of normal B-cell ontogeny. Blood 1990; 76: 1647-1656.
2. Gerritsen EJA, Tol MJD van, Lankester AC et al. Immunoglobulin levels and monoclonal gammopathies in children after bone marrow transplantation. Blood 1993; 82: 3493-3502.
3. Gerritsen EJA, Tol MJD van, Veer MB van't et al. Clonal dysregulation of the antibody response to tetanus-toxoid after bone marrow transplantation. Blood 1994; 84: 4374-4382.
4. Ghory P, Schiff S, Buckley R. Appearance of multiple benign paraproteins during early engraftment of soy lectin T cell-depleted haploidentical bone marrow cells in severe combined immunodeficiency. J Clin Immunol 1986; 6: 161-169.
5. Gerritsen E, Vossen J, Tol M van et al. Monoclonal gammopathies in children. J Clin Immunol 1989, 9: 296-305.
6. Mitus AJ, Stein R, Rappeport JM et al. Monoclonal and oligoclonal gammopathy after bone marrow transplantation. Blood 1989; 74: 2764-2768.
7. Kent EF, Crawford J, Cohen HJ, Buckley RH. Development of multiple monoclonal serum immunoglobulins (multiclonal gammopathy) following both HLA-identical unfractionated and T cell-depleted haploidentical bone marrow transplantation in severe combined immunodeficiency. J Clin Immunol 1990; 10: 106-114.
8. Seligmann M, Brouet JC. Antibody activity of human myeloma globulins. Semin Hematol 1973; 10: 163-177.
9. Merlini G, Farhangi M, Osserman EF. Monoclonal immunoglobulins with antibody activity in myeloma, macroglobulinemia and related plasmacell dyscrasias. Semin Oncol 1986; 13: 350-365.
10. Wagemaker G, Heidt PJ, Merchav S, Bekkum DW van. Abrogation of histo-incompatibility barriers in Rhesus monkeys. In: Baum SJ, Ledney GD, Thierfelder S (eds). Experimental Haematology Today. Karger: Basel. 1982, pp 111-118.
11. Vossen JM, Heidt PJ, Berg H van den et al. Prevention of infection and graft-versus-host disease by suppression of intestinal microflora in children treated with allogeneic bone marrow transplantation. Eur J Clin Microbiol Infect Dis 1990; 9: 14-23.
12. Labadie J, Tol MJD van, Dijkstra NH et al. Transfer of specific immunity from donor to recipient of an allogeneic bone marrow graft: effect of conditioning on the specific immune response of the graft recipient. Br J Haematol 1992; 80: 381-390.
13. Labadie J, Tol MJD van, Dijkstra NH et al. Transfer of specific immunity from donor to recipient of an allogeneic bone marrow graft: evidence for donor origin of the antibody producing cells. Br J Haematol 1992; 82: 437-444.
14. Gratama JW, Oosterveer MAP, Lepoutre JMM et al. Serological and molecular studies of Epstein-Barr virus infection in allogeneic marrow graft recipients. Transplantation 1990; 49: 725-730.
15. Venrooij WJ van, Maine RN, Manual of Biological Markers of Disease. Section A: Methods of Autoantibody Detection. Kluwer Acad Pubi: Dordrecht. 1993.
16. Graeff-Meeder ER de, Rijkers GT, Voorhorst-Ogink MM et al. Antibodies to human HSP60 in patients with juvenile chronic arthritis, diabetes mellitus and cystic fibrosis. Pediatr Res 1993; 34: 424-428.
17. Otten HG, Daha MR, Rooy HH de, Breedveld FC. Quantitative detection of class-specific rheumatoid factors using mouse monoclonal antibodies and the biotin/streptavidin enhancement system. Br J Rheum 1989; 28: 310-316.
18. Nooy FJM, Sluijs-Gelling AJ van der, Jol-van der Zijde CM et al. Immunoblotting techniques for the detection of low level homogeneous immunoglobulin components in serum. J Immunol Methods 1990; 134: 273-281.
19. Boström L, Ringdén O. Viral infections. In: Atkinson K (ed). Clinical Bone Marrow Transplantation. Cambridge University Press: Cambridge, 1994, pp 344-355.
20. Shulman HM, Sullivan KM, Weiden PL et al. Chronic graft-versus-host syndrome in man: a long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204-217.
21. Smith CIE, Hammarström L, Lefvert AK. Bone-marrow grafting induces acerylcholine receptor antibody formation. Lancet 1985, i: 978 (letter).
22. Tazzari PL, Gobbi M, Zauli D et al. Close association between antibodies to cytoskeletal intermediate filaments, and chronic graft-versus-host disease. Transplantation 1987; 44: 234-236.
23. Dighiero G, Intrator L, Cordonnier C et al. High levels of anti-cytoskeleton autoantibodies are frequently associated with chronic GVHD. Br J Haematol 1987; 67: 301-305.
24. Lister J, Messner H, Keystone E et al. Autoantibody analysis of patients with graft versus host disease. J Clin Lab Immunol 1987; 24: 19-23.
25. Rouquette-Gally AM, Boyeldieu D, Prost AC, Gluckman E. Autoimmumty after allogeneic bone marrow transplantation: a study of 53 long-term-surviving patients. Transplantation 1988; 46: 238-240.
26. Smith CIE, Norberg R, Isenberg D et al. Anti-DNA antibody synthesis after bone marrow transplantation: implications for IgG subclass restrictivity and pathogenicity of autoantibodies. Bone Marrow Transplant 1988; 3: 583-588.
27. Cikes N, Momoi MY, Williams CL et al. Striational autoantibodies. quantitative detection by enzyme immunoassay in myasthenia gravis, thymoma, and recipients of D-penicillamine or allogeneic bone marrow. Mayo Clin Proc 1988; 63: 474-481.
28. Smith CIE, Norberg R, Möller G et al. Autoantibody formation after bone marrow transplantation: comparison between acetylcholine receptor antibodies and other autoantibodies and analyses of HLA and Gm markers. Eur Neurol 1989; 29: 128-134.
29. Holmes JA, Livesey SJ, Bedwell AE et al. Autoantibody analysis in chronic graft-versus-host disease. Bone Marrow Transplant 1989; 4: 529-531.
30. Kier P, Penner E, Bakos S et al. Autoantibodies in chronic GVHD: high prevalence of antinucleolar antibodies. Bone Marrow Transplant 1990; 6: 93-96.
31. Sanmarco M, Vialettes, Maraninchi D, Bernard D. Autoantibody formation after transplantation: a comparison between autologous and allogeneic grafts. Autoimmunity 1991; 11: 7-12.
32. Siegert W, Stemerowicz R, Hopf U. Antimitochondrial antibodies in patients with chronic graft-versus-host-disease. Bone Marrow Transplant 1992; 10: 221-227.
33. Lortan JE, Rochfort NC, El-Tumi M, Vellodi A. Autoantibodies after bone marrow transplantation in children with genetic disorders: relation to chronic graft-versus-host-disease. Bone Marrow Transplant 1992; 9: 325-330.
34. Bos NA, Meeuwsen CG, Wijngaarden P van, Benner R. B cell repertoire in adult antigen-free and conventional neonatal BALB/c mice. II. Analysis of antigen-binding capacities in relation to VH gene usage. Eur J Immunol 1989; 19: 1817-1822.
35. Jerne NK. Idiotypic networks and other preconceived ideas. Immunol Rev 1984; 79: 5-24.
36. Geha RS. Presence of circulating anti-idiotype-bearing cells after booster immunization with tetanus toxoid (TT) and inhibition of anti-TT antibody synthesis by auto-anti-idiotypic antibody. J Immunol 1983; 130: 1634-1639.
37. Saxon A, Barnett E. Human auto-antiidiotypes regulating T cell-mediated reactivity to tetanus toxoid. J Clin Invest 1984; 73: 342-348.
38. Lefvert AK. Auto-anti-idiotypic immunity and acetylcholine receptors. Concepts Immunopathol 1986; 3: 285-310.
39. Berg P van den, Radl J, Löwenberg B, Swart ACW. Homogeneous antibodies in lethally irradiated and autologous bone marrow reconstituted monkeys. Clin Exp Immunol 1976; 23: 355-359.
40. Radl J. Idiopathic paraproteinemia - a consequence of an agerelated deficiency in the T immune system. Three-stage development - a hypothesis. Clin Immunol Immonopathol 1979; 14: 251-255.